Clinical Trial Update: Hypofractionated Stereotactic Boost in Prostate Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update on hypofractionated stereotactic boost for prostate cancer, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Centre Oscar Lambret | Conditions: Cancer | Phase 2 | Status: COMPLETED